Jailendra Singh

“Actually, I want to ask about the large pharma partnership. Are you seeing any meaningful changes in wallet share there or sourcing behavior among your largest pharma customers heading into next year?”

“If I take all your comments and put the pieces together, is the message that BetterHelp revenue will still decline next year, but probably exit the year growing year over year on top line?”

“With all the coverage changes we've been seeing year to date around Medicaid exchanges, have you seen any of that impact your business positively or negatively thus far?”

“A quick follow-up there, as you look at these type of lives, industries, these lives are coming from expected utilization or number of offerings they might have access to.”

“So I want to talk about the 2026 medical margin guidance, updated guidance clearly includes current year medical cost performance. I think we calculated $36 million PYD year-to-date, and that some changes around risk adjustment.”